DARTMOUTH-HITCHCOCK MEDICAL CENTER
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1983-01-01
- Employees
- 10K
- Market Cap
- -
Tumor Specific Plasma DNA
- Conditions
- First Posted Date
- 2012-06-13
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT01617915
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-06-05
- Last Posted Date
- 2014-11-13
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Registration Number
- NCT01611584
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
- Conditions
- Interventions
- First Posted Date
- 2012-04-24
- Last Posted Date
- 2014-09-18
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 131
- Registration Number
- NCT01583400
- Locations
- 🇺🇸
Family Medicine Clinics, Cheshire Medical Center (DH-Keene), Keene, New Hampshire, United States
The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing
- Conditions
- Interventions
- First Posted Date
- 2012-04-19
- Last Posted Date
- 2013-07-19
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01580423
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Metronomic Therapy in Patients With Metastatic Melanoma
- Conditions
- Interventions
- First Posted Date
- 2012-03-02
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 7
- Registration Number
- NCT01542255
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors
- Conditions
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2012-08-28
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Registration Number
- NCT01521299
Phase II Study of Alternating Sunitinib and Temsirolimus
- Conditions
- Interventions
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 37
- Registration Number
- NCT01517243
- Locations
- 🇺🇸
University of Vermont, Vermont Cancer Center, Burlington, Vermont, United States
🇺🇸Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer
- First Posted Date
- 2012-01-16
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT01510405
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
- Conditions
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT01466504
- Locations
- 🇺🇸
White River Junction VA Medical Center, White River Junction, Vermont, United States
🇺🇸Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
- First Posted Date
- 2011-11-02
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT01463852
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire, United States